Kidney biopsies are essential for diagnosing kidney disorders in both native and transplanted kidneys1,2. However, the increasing incidence of biopsies yielding insufficient tissue for diagnosis presents a dual challenge: it strains the healthcare system and endangers patients, who may require re-biopsy or face the risk of inaccurate diagnoses due to unsampled disease3. Traditionally, real-time assessment of biopsy adequacy has been performed by pathologists using microscopes4. Unfortunately, due to cost and staffing constraints, many institutions cannot have a pathologist present at the time of biopsy.
No takes yet. Share an insight, caveat, or question.
Ahangaran et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: